Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues.
about
Arrhythmias in women2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theFemale-specific aspects in the pharmacotherapy of chronic cardiovascular diseasesAmiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.Domperidone: review of pharmacology and clinical applications in gastroenterology.Sex- and gender-specific research priorities for the emergency management of heart failure and acute arrhythmia: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup.Dofetilide induced torsade de pointes: mechanism, risk factors and management strategies.How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity.Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation.Pharmacological modulation of gap junction function with the novel compound rotigaptide: a promising new principle for prevention of arrhythmias.Atrial fibrillation catheter ablation in females: same hardware, different findings.Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation.Impact of sex and ethnicity on arrhythmic risk.Ventricular anti-arrhythmic effects of heptanol in hypokalaemic, Langendorff-perfused mouse heartsDeterminants of torsades de pointes in older patients with drug-associated long QT syndrome: a case-control study.Comparison of the effects of IK,ACh, IKr, and INa block in conscious dogs with atrial fibrillation and on action potentials in remodeled atrial trabeculae.Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.Slow Recovery of Excitability Increases Ventricular Fibrillation Risk as Identified by Emulation
P2860
Q26823099-0819BE37-8D5C-4BD1-90D1-78ADBF4CAA9AQ28087002-EF3F8C43-311D-4860-BF7A-FF332E846EF2Q28182631-53A6C4D2-7C92-4825-A4B1-35058FD8FCA9Q34068720-F7F2BE53-A0D1-4010-B654-D8C3A61ADB85Q34626516-3E2CABFA-9370-4EE4-8F17-7A8D3CDF744AQ34836591-35204072-057B-4660-8EF2-22B7A259BBA2Q35028720-2730B3CA-8271-4996-AF1C-1DDD7AD54851Q35376878-AD1A9702-0369-4E73-82DF-06E94D2BBD85Q36713626-1F4E9FFD-7282-44BD-8281-49BFA876F2BFQ36936412-F47DA68E-9A6D-4820-B501-A44CC86E99D4Q37953464-045F9CFA-ABFA-4D5E-A7D0-19F5DB33C7B3Q38155163-A369D28E-576D-4F34-8C37-6A63A9377722Q38508942-88E8487A-BB0D-4512-817F-53FEC2DEC853Q38719030-EBA79ACF-C091-4EFF-BF21-70148CC06A30Q43901924-84845A2A-D078-4897-B721-21E6DDE416F8Q47254019-0AC86A4D-1D96-4C0F-8BE9-4440F73EAA4CQ47681875-91EEA612-00DC-4990-813E-859D921A117DQ58698119-E7953538-6008-44D4-8423-32AEECFBF7FD
P2860
Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Risk of proarrhythmia with cla ...... differences and other issues.
@ast
Risk of proarrhythmia with cla ...... differences and other issues.
@en
type
label
Risk of proarrhythmia with cla ...... differences and other issues.
@ast
Risk of proarrhythmia with cla ...... differences and other issues.
@en
prefLabel
Risk of proarrhythmia with cla ...... differences and other issues.
@ast
Risk of proarrhythmia with cla ...... differences and other issues.
@en
P1476
Risk of proarrhythmia with cla ...... differences and other issues.
@en
P2093
Deborah L Wolbrette
P304
P356
10.1016/S0002-9149(02)03378-7
P407
P577
2003-03-01T00:00:00Z